DRREDDY:NSE
Dr Reddy's Laboratories Ltd
₹ 1,199.80
arrow_upward
+1.68%(+19.80) Siku 1
9 Okt, 15:30:00 GMT +5:30 · INR
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya DRREDDY...
Fungua
₹ 1,180.00
Juu
₹ 1,200.80
Chini
₹ 1,172.00
Mtaji wa soko
997.09B
Wastani wa kiasi cha mauzo
1.81M
Kiasi cha mauzo ya hisa
1.51M
Gawio
0.67%
Mgawo wa faida wa kila robo mwaka
₹ 2.00
Tarehe ya kutojumuisha gawio
10 Jul 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
31.03
Juu kwa wiki 52
₹ 1,414.90
Chini kwa wiki 52
₹ 1,101.00
EPS
₹ 38.67
Hisa za wawekezaji
166.06M
Idadi ya wafanyakazi
elfu 28
Fungua
₹ 1,180.00
Juu
₹ 1,200.80
Chini
₹ 1,172.00
Mtaji wa soko
997.09B
Wastani wa kiasi cha mauzo
1.81M
Kiasi cha mauzo ya hisa
1.51M
Gawio
0.67%
Mgawo wa faida wa kila robo mwaka
₹ 2.00
Tarehe ya kutojumuisha gawio
10 Jul 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
31.03
Juu kwa wiki 52
₹ 1,414.90
Chini kwa wiki 52
₹ 1,101.00
EPS
₹ 38.67
Hisa za wawekezaji
166.06M
Idadi ya wafanyakazi
elfu 28
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Yahoo Finance
·
dakika 46 zilizopita
The S&P 500 Just Hit a Record High -- Here's How Much Higher It Can Climb, According to the Wall Street Consensus
Brave New Coin
·
dakika 38 zilizopita
Evernorth XRP Treasury Merger Brings 473 Million XRP to Nasdaq as XRPN Debuts October 12
24/7 Wall St.
·
saa 3 zilizopita
KLA Turned $1,000 Into $31,595 in a Decade, Crushing the S&P 500 by 8.7x
Wasifu
Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad, with U.S. headquarters in East Brunswick, New Jersey. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology.
Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe.
By 2007, Dr. Wikipedia
Kuhusu Dr Reddy's Laboratories Ltd
Afisa Mkuu Mtendaji (CEO)Erez Israeli
Wafanyakazielfu 27.5
Lilianzishwa1984
Makao makuuHyderabad, Andhra Pradesh, India
Sekta-
Tovutidrreddys.com